Anemia Drugs Market Overview & Potential Growth Opportunities 2020-2025

  • Report ID: BMRC 448 | Number of pages: 197 | Published Date: Jan 2020

    Published | Category: Healthcare | Delivery Timeline: 48 hrs

To know the impact of COVID-19 On Anemia Drugs Market Overview & Potential Growth Opportunities 2020-2025 Market

Request Now
Market Size Forecast Scenarios (Optimistic, Baseline and Pessimistic) 2021-2027

Anemia Drugs Market report is segmented on the basis of anemia type, end-user and region & country level. Based upon anemia type, global anemia drugs market is segmented into iron deficiency anemia, sickle cell anemia, aplastic anemia, hemolytic anemia, pernicious anemia and others. Based on end-user, the anemia drugs market is segmented into hospitals, private clinics and other.

Anemia Drugs Market is valued at USD 26292.3 Million in 2018 and expected to reach USD 55279.2 Million by 2025 with the CAGR of 11.20% over the forecast period.

Market Analysis of Anemia Drugs-

Anemia is a set of conditions characterized by weakness, shortness of breath and a general tiredness due to a decrease in the total amount of red blood cells (RBCs) or hemoglobin in the blood. Anemia is a common cause of qualitative or quantitative deficiency of hemoglobin. Hemoglobin is iron rich protein that carries the oxygen from lungs to the other parts of body tissue. The hemoglobin deficiency is generally associated with the decrease in the number of red blood cells and hematocrit. Anemia causes low transfer of oxygen to the rest of the body. It is easily preventable and treated however, there are mild or vague symptoms for detection of anemia due to which anemia mostly goes undetectable.

The regions covered in this Global Anemia Drugs Market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, the market of anemia drugs is sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, Middle East Asia (UAE, Saudi Arabia, Egypt) GCC, Africa, etc.

Key Players -

Some of the key players in Global Anemia Drugs market are: Amgen Inc., Meda Cuonsumer Healthcare Inc., Johnson and Johnson, Emmaus Medical Inc., Keryx Biopharmaceuticals, Inc., Abbvie Inc, GlaxoSmithKline plc, Pfizer Inc., Allergan Inc., F. Hoffmann La Roche AG, and others.

High Prevalence of Anemia is One of the Major Factors Driving the Growth of Global Anemia Drugs Market.

The increasing rate of nutritional deficiency is one of the major driving factors of anemia drugs market  globally. The increase in prevalence of chronic diseases and unhealthy life styles and growing baby bloomer population are some of the factors boosting the growth of anemia drugs market. In addition, increasing government initiatives in improving the healthcare facilities in developing countries is also supplementing the market growth.  However, adverse effects associated with the medications of anemia drugs may hamper the market growth. Moreover, increasing research and development associated with the anemia drugs can create new opportunities for the market growth of anemia drugs during the forecast period. Furthermore, the highest number of individuals affected with anemia after pre-school-age children are non-pregnant women which are around 31.2% of the total anemic population. As per WHO, globally anaemia affects 1.62 billion people, which corresponds to 24.8% of the population. The highest prevalence is in preschool-age children and the lowest prevalence is in men. However, the population group with the greatest number of individuals affected is non-pregnant women.

North America is expected to Dominate the Anemia Drug Market.

By region, the global anemia drugs market has been segmented into North America, Europe, Asia Pacific, and the Middle East & Africa. Globally, North America is the largest market for anemia drugs owing to increasing healthcare infrastructure and  advanced technology, high research activities and growing awareness about anemia in this region. Asia pacific region is anticipated to show  the fastest growth due to increasing health care expenditure and disposable income, high prevalence of chronic diseases and increasing geriatric population.

Key Benefits for Market Reports –

  • Global market report covers in depth historical and forecast analysis.
  • Global market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market opportunities, Competitive Analysis, Regional and Country Level.
  • Global market report helps to identify opportunities in market place.
  • Global market report covers extensive analysis of emerging trends and competitive landscape.

Market Segmentation:-

By Anemia Type:

  • Iron Deficiency Anemia
  • Sickle Cell Anemia
  • Aplastic Anemia
  • Hemolytic Anemia
  • Pernicious Anemia
  • Others

By End-User:

  • Hospitals
  • Private Clinics
  • Others

By Regional & Country Level:

  • North America
    • US.
    • Canada
  • Europe
    • UK.
    • France
    • Germany
    • Italy
  • Asia Pacific
    • China
    • Japan
    • India
    • Southeast Asia
  • Latin America
    • Brazil
    • Mexico
  • Middle East and Africa
    • GCC
    • Africa
    • Rest of Middle East and Africa

Interested in this report?

Anemia Drugs Market Share and Growth to 2025

report cover

Anemia Drugs Market Overview & Potential Growth Opportunities 2020-2025

Note: For delivery of sample pages you must have a Domain Specific Email ID, normally your business email address complies. Generic Email IDs such as AOL, Hotmail, Yahoo, Gmail, MSNetc. are not accepted.
Brandessence market research actively tracks, monitors, and analyses key industry trends in real-time via B2B surveys in 60 + countries and territories.


Looking for Regional Reports?